Doctor Tomoaki Okada
Kagawa Prefectural Central Hospital, Takamatsu (Japan)
Member of:
/f/125658/3386x1417/951de003e4/hfa-acronym-name-rgb.png)
Feasibility and safety of early initiation of a PCSK9 (proprotein convertase subtilisin/kexin type 9) inhibitor in patients with acute myocardial infarction undergoing primary PCI
Event: ESC Congress 2020
Topic: Lipid-Lowering Agents
Session: Pharmacology and Pharmacotherapy ePosters
ESC 365 is supported by
